Literature DB >> 8358994

Chronic destructive monoarthritis of the wrist in patients with anti-SSA/Ro antibodies: report of two cases.

M Satoh1, H Yamagata, F Watanabe, Y Matsushita, S Nakayama, K Okubo, M Akizuki.   

Abstract

Among 340 patients with rheumatic diseases, two cases of chronic destructive monoarthritis of the wrist with anti-SSA/Ro antibodies and rheumatoid factor, were observed for over three years. It is not clear whether these cases represent a specific subset of rheumatoid arthritis (RA) or whether they may progress to diffuse symmetrical destructive polyarthritis typical of RA. Long-term follow-up studies including analysis of autoantibodies will be needed to clarify the characteristics and course of chronic monoarthritis.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8358994     DOI： 10.1007/bf02231543

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  10 in total

1.  MONARTHRITIS. A STUDY OF FORTY-FIVE CASES.

Authors:  D A PITKEATHLY; H E GRIFFITHS; M CATTO
Journal:  J Bone Joint Surg Br       Date:  1964-11

2.  Rheumatoid arthritis in south-east Europe.

Authors:  P G Vlachoyiannopoulos; H M Moutsopoulos
Journal:  Baillieres Clin Rheumatol       Date:  1992-02

3.  Clinical and histologic observations of monoarthritis. Anticipation of its progression to rheumatoid arthritis.

Authors:  T Iguchi; T Matsubara; K Kawai; K Hirohata
Journal:  Clin Orthop Relat Res       Date:  1990-01       Impact factor: 4.176

4.  Chronic monarticular synovitis. Diagnostic and prognostic features.

Authors:  M R Fletcher; J T Scott
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

5.  Monoarthritis, clinical and histological examination.

Authors:  G Rasmussen; I Reimann; R B Andersen
Journal:  Scand J Rheumatol       Date:  1973       Impact factor: 3.641

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  Clinical implications of the presence of anti-Ro (SSA) antibodies in patients with rheumatoid arthritis.

Authors:  F N Skopouli; A P Andonopoulos; H M Moutsopoulos
Journal:  J Autoimmun       Date:  1988-08       Impact factor: 7.094

8.  Long-term prognosis of monoarthritis. A follow-up study.

Authors:  K Kaarela; S Tiitinen; R Luukkainen
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

9.  Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects.

Authors:  H M Moutsopoulos; F N Skopouli; A K Sarras; C Tsampoulas; A K Mavridis; S H Constantopoulos; P J Maddison
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

10.  Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis.

Authors:  G Boire; H A Ménard
Journal:  J Rheumatol       Date:  1988-03       Impact factor: 4.666
  10 in total
  1 in total

1.  Multiple tendon ruptures in a patient affected by anti-SSA/Ro antibody positive rheumatoid arthritis.

Authors:  P Caramaschi; D Biasi; A Carletto; T Manzo; M Randon; M L Pacor; L M Bambara
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.